The use of cerebrospinal fluid in biomarker studies

Research output: Chapter in Book/Report/Conference proceedingChapterAcademicpeer-review

Abstract

Cerebrospinal fluid (CSF) is an extremely useful matrix for biomarker research for several purposes, such as diagnosis, prognosis, monitoring, and identification of prominent leads in pathways of neurologic diseases. Such biomarkers can be identified based on a priori hypotheses around prominent protein changes, but also by applying -omics technologies. Proteomics is widely used, but metabolomics and transcriptomics are rapidly revealing their potential for CSF studies. The basis of such studies is the availability of high-quality biobanks. Furthermore, profound knowledge and consequent optimization of all aspects in biomarker development are needed. Here we discuss current knowledge and recently developed protocols for successful biomarker studies, from collection of CSF by lumbar puncture, processing, and biobanking protocols, preanalytic confounding factors, and cost-efficient development and validation of assays for implementation into clinical practice or research.

Original languageEnglish
Title of host publicationHandbook of Clinical Neurology
PublisherElsevier B.V.
Pages3-20
Number of pages18
DOIs
Publication statusPublished - 1 Jan 2017

Publication series

NameHandbook of Clinical Neurology
Volume146
ISSN (Print)0072-9752
ISSN (Electronic)2212-4152

Cite this

Teunissen, C. E., Verheul, C., & Willemse, E. A. J. (2017). The use of cerebrospinal fluid in biomarker studies. In Handbook of Clinical Neurology (pp. 3-20). (Handbook of Clinical Neurology; Vol. 146). Elsevier B.V.. https://doi.org/10.1016/B978-0-12-804279-3.00001-0
Teunissen, C. E. ; Verheul, C. ; Willemse, E. A.J. / The use of cerebrospinal fluid in biomarker studies. Handbook of Clinical Neurology. Elsevier B.V., 2017. pp. 3-20 (Handbook of Clinical Neurology).
@inbook{864387fbaedd4a56bb2c15d87011bd6d,
title = "The use of cerebrospinal fluid in biomarker studies",
abstract = "Cerebrospinal fluid (CSF) is an extremely useful matrix for biomarker research for several purposes, such as diagnosis, prognosis, monitoring, and identification of prominent leads in pathways of neurologic diseases. Such biomarkers can be identified based on a priori hypotheses around prominent protein changes, but also by applying -omics technologies. Proteomics is widely used, but metabolomics and transcriptomics are rapidly revealing their potential for CSF studies. The basis of such studies is the availability of high-quality biobanks. Furthermore, profound knowledge and consequent optimization of all aspects in biomarker development are needed. Here we discuss current knowledge and recently developed protocols for successful biomarker studies, from collection of CSF by lumbar puncture, processing, and biobanking protocols, preanalytic confounding factors, and cost-efficient development and validation of assays for implementation into clinical practice or research.",
keywords = "analytics, assay development, biobanking, biomarker discovery, Biomarkers, cerebrospinal fluid, lumbar puncture, pre-analytics, proteomics",
author = "Teunissen, {C. E.} and C. Verheul and Willemse, {E. A.J.}",
year = "2017",
month = "1",
day = "1",
doi = "10.1016/B978-0-12-804279-3.00001-0",
language = "English",
series = "Handbook of Clinical Neurology",
publisher = "Elsevier B.V.",
pages = "3--20",
booktitle = "Handbook of Clinical Neurology",

}

Teunissen, CE, Verheul, C & Willemse, EAJ 2017, The use of cerebrospinal fluid in biomarker studies. in Handbook of Clinical Neurology. Handbook of Clinical Neurology, vol. 146, Elsevier B.V., pp. 3-20. https://doi.org/10.1016/B978-0-12-804279-3.00001-0

The use of cerebrospinal fluid in biomarker studies. / Teunissen, C. E.; Verheul, C.; Willemse, E. A.J.

Handbook of Clinical Neurology. Elsevier B.V., 2017. p. 3-20 (Handbook of Clinical Neurology; Vol. 146).

Research output: Chapter in Book/Report/Conference proceedingChapterAcademicpeer-review

TY - CHAP

T1 - The use of cerebrospinal fluid in biomarker studies

AU - Teunissen, C. E.

AU - Verheul, C.

AU - Willemse, E. A.J.

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Cerebrospinal fluid (CSF) is an extremely useful matrix for biomarker research for several purposes, such as diagnosis, prognosis, monitoring, and identification of prominent leads in pathways of neurologic diseases. Such biomarkers can be identified based on a priori hypotheses around prominent protein changes, but also by applying -omics technologies. Proteomics is widely used, but metabolomics and transcriptomics are rapidly revealing their potential for CSF studies. The basis of such studies is the availability of high-quality biobanks. Furthermore, profound knowledge and consequent optimization of all aspects in biomarker development are needed. Here we discuss current knowledge and recently developed protocols for successful biomarker studies, from collection of CSF by lumbar puncture, processing, and biobanking protocols, preanalytic confounding factors, and cost-efficient development and validation of assays for implementation into clinical practice or research.

AB - Cerebrospinal fluid (CSF) is an extremely useful matrix for biomarker research for several purposes, such as diagnosis, prognosis, monitoring, and identification of prominent leads in pathways of neurologic diseases. Such biomarkers can be identified based on a priori hypotheses around prominent protein changes, but also by applying -omics technologies. Proteomics is widely used, but metabolomics and transcriptomics are rapidly revealing their potential for CSF studies. The basis of such studies is the availability of high-quality biobanks. Furthermore, profound knowledge and consequent optimization of all aspects in biomarker development are needed. Here we discuss current knowledge and recently developed protocols for successful biomarker studies, from collection of CSF by lumbar puncture, processing, and biobanking protocols, preanalytic confounding factors, and cost-efficient development and validation of assays for implementation into clinical practice or research.

KW - analytics

KW - assay development

KW - biobanking

KW - biomarker discovery

KW - Biomarkers

KW - cerebrospinal fluid

KW - lumbar puncture

KW - pre-analytics

KW - proteomics

UR - http://www.scopus.com/inward/record.url?scp=85040668098&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-804279-3.00001-0

DO - 10.1016/B978-0-12-804279-3.00001-0

M3 - Chapter

T3 - Handbook of Clinical Neurology

SP - 3

EP - 20

BT - Handbook of Clinical Neurology

PB - Elsevier B.V.

ER -

Teunissen CE, Verheul C, Willemse EAJ. The use of cerebrospinal fluid in biomarker studies. In Handbook of Clinical Neurology. Elsevier B.V. 2017. p. 3-20. (Handbook of Clinical Neurology). https://doi.org/10.1016/B978-0-12-804279-3.00001-0